Stone Warren bought NEO
May 2, 2026 · Form 4 insider transaction
Stone Warren bought 5,969 shares of NeoGenomics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,969
Price
$0.00
Total value
N/A
InsiderStone Warren
Role—
CompanyNeoGenomics, Inc. (NEO)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 2, 2026
Filing dateMay 5, 2026
Shares owned after164,334
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the release of restricted stock units that were previously reported on a Form 4.; Each restricted stock unit is the economic equivalent of one share of NeoGenomics, Inc. common stock and is converted into common stock upon vesting.